A Study of LY3502970 in Participants With Type 2 Diabetes
Part of paid clinical trials in Hialeah, Florida.
- Sponsor
- Eli Lilly and Company
- Study ID
- NCT04426474
- Phase
- PHASE1
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- LY3502970 — DRUGAdministered orally.
- Placebo — DRUGAdministered orally.
Study Details
The main purpose of this study is to learn more about the safety of LY3502970 and any side effects that might be associated with it. Blood tests will be done to measure how much LY3502970 is in the bloodstream, how long it takes the body to eliminate it, and how it affects blood sugar. Participation could last up to 18 weeks and may include up to 14 visits (including three overnight stays) in the study center.
Key Dates
- Start date
- Oct 8, 2020
- Status verified
- Apr 2026
- Primary completion
- Jul 12, 2021
- Completion
- Jul 12, 2021
Study Design
- Enrollment
- 68 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: LY35029703, 6, 9, 12, 15, 21, 27, 36 and 45 milligrams (mg) LY3502970 administered orally.
- Placebo Comparator: PlaceboPlacebo administered orally.
Primary Outcome Measure
Number of Participants With One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug [ Time Frame: Baseline through Follow-up (up to Day 105) ]
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Clinical Pharmacology of Miami | Hialeah | Florida | 33014 | - |
| Hassman Research Institute | Marlton | New Jersey | 08053 | - |
| Midwest Clinical Research Unit | Dayton | Ohio | 45417 | - |
| Endeavor Clinical Trials | San Antonio | Texas | 78229 | - |
Related coverage on Hipa.ai
- Orforglipron Phase 1 Trial for Type 2 Diabetes Reports No Drug-Related SAEsOrforglipron · May 26, 2026 · ClinicalTrials.gov
Find similar trials in Hialeah, FL
By condition
By specialty
Related Studies
- Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)Recruiting · The University of Texas Health Science Center at San Antonio · San Antonio, Texas
- Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)Recruiting · Ohio State University · Columbus, Ohio
- Increasing Uptake of EHR-enabled Population Health Outreach Strategies to Improve Diabetes ScreeningEnrolling By Invitation · University of Texas Southwestern Medical Center · Dallas, Texas
- Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care SettingsEnrolling By Invitation · Rutgers, The State University of New Jersey · New Brunswick, New Jersey